Successful platform test with Breast and Glioblastoma PDX cell lines

Platform successfully demonstrated on prototype devices to demonstrate single cell dormancy, migration, and clonogenic assays with both Glioblastoma (brain) cancer and breast cancer patient derived cell lines.